Australia: The novel triple agonist retatrutide significantly reduced the apnea-hypopnea index (AHI) in adults with obesity or overweight and obstructive sleep apnea (OSA), regardless of type 2...
This is a summary. For the full story, refer to the original source. Public of India presents verified citizen-relevant reporting.